Iovance Biotherapeutics

Iovance Biotherapeutics Vendor Risk Report

This vendor risk report is based on UpGuard’s continuous monitoring of Iovance Biotherapeutics's security posture using open-source, commercial, and proprietary threat intelligence feeds. The results are summarized into a security rating based on the analysis of hundreds of individual checks across five risk categories: website security, email security, phishing & malware, brand & reputation risk, and network security.

Security reports related to Iovance Biotherapeutics